Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius    FRE   DE0005785604

FRESENIUS

(FRE)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/17/2019 05/20/2019 05/21/2019 05/22/2019 05/23/2019 Date
48.81(c) 46.965(c) 47.15(c) 47.725(c) 47.27(c) Last
2 148 516 1 771 311 1 156 849 1 405 181 1 820 444 Volume
-0.41% -3.78% +0.39% +1.22% -0.95% Change
More quotes
Financials (EUR)
Sales 2019 35 230 M
EBIT 2019 4 680 M
Net income 2019 1 884 M
Debt 2019 17 722 M
Yield 2019 1,70%
Sales 2020 37 102 M
EBIT 2020 5 004 M
Net income 2020 2 054 M
Debt 2020 16 387 M
Yield 2020 1,80%
P/E ratio 2019 14,35
P/E ratio 2020 13,28
EV / Sales2019 1,26x
EV / Sales2020 1,16x
Capitalization 26 557 M
More Financials
Company
Fresenius specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (52.4%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis,... 
More about the company
Surperformance© ratings of Fresenius
Trading Rating : Investor Rating :
More Ratings
Latest news on FRESENIUS
05/20FRESENIUS : Ex-dividend day for final dividend
FA
05/17ANNUAL GENERAL MEETING : Fresenius on course for continued growth, 26th straight..
PU
05/16FRESENIUS : Medical Care stays on course for growth – Annual General Meeti..
PU
05/03FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by ..
EQ
05/02Fresenius makes solid start to year after turbulent 2018
RE
05/02FRESENIUS : makes solid start to 2019 and confirms Group guidance
PU
05/02FRESENIUS : Backs Guidance After Sales, Operating Profit Rose in 1Q
DJ
04/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
04/29PAUL ACHLEITNER : Deutsche Bank's Achleitner best-paid chairman of German compan..
RE
04/23FRESENIUS : Helios becomes medical partner at Rafa Nadal Academy
PU
More news
Analyst Recommendations on FRESENIUS
More recommendations
Stock Trading Strategies
FRESENIUS - 02/04
A trend reversal is in sight
BUY
More Stock Trading Analysis
Sector news : Hospitals, Clinics & Primary Care Services
05/15CVS HEALTH : to Require Third-Party Testing of Vitamins, Supplements
DJ
05/14What's at stake for Europe Inc in a trade spat with Washington
RE
05/06PREMIER : to Exit Specialty Pharmacy Operations in Deal With CVS Unit
DJ
05/06EXCLUSIVE : Hedge funds target Centene, may oppose WellCare deal - sources
RE
05/02CVS HEALTH : to Close 46 Pharmacy Locations - Update
DJ
More sector news : Hospitals, Clinics & Primary Care Services
Chart FRESENIUS
Duration : Period :
Fresenius Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS
Short TermMid-TermLong Term
TrendsBearishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 57,3 €
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS11.54%29 604
BANGKOK DUSIT MEDICAL SERVICES PCL--.--%12 858
AIER EYE HOSPITAL GROUP CO LTD--.--%12 511
IHH HEALTHCARE BHD--.--%11 088
RAMSAY HEALTH CARE LIMITED18.83%9 528
HAPVIDA PARTICIPACOES E INVESTIMENTOS SA18.53%6 089